Profil
Samuel Henderson is currently the Chief Scientific Officer at Cerecin, Inc. Previously, he worked as a Principal at The University of Colorado and as a Lead Scientist at Genoplex, Inc. He completed his undergraduate degree at the University of Washington and obtained his doctorate from the University of Chicago.
Aktive Positionen von Samuel Henderson
| Unternehmen | Position | Beginn |
|---|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Samuel Henderson
| Unternehmen | Position | Ende |
|---|---|---|
Genoplex, Inc.
Genoplex, Inc. Packaged SoftwareTechnology Services Develops AI-powered technology platform to simplify the logistics of patient referrals for advanced therapies | Technik-/Wissenschafts-/F&E-Leiter | - |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Samuel Henderson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat central nervous system disorders | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genoplex, Inc.
Genoplex, Inc. Packaged SoftwareTechnology Services Develops AI-powered technology platform to simplify the logistics of patient referrals for advanced therapies | Technology Services |
















